New therapeutic agents for the treatment of insulin resistance and NIDDM

Drug Discovery Today

Volumn 1, Issue 3, 1996, Pages 109-116

  Turner, Nicholas C ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0000673973     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/1359-6446(96)89039-8     Document Type: Review

References (73)

1. Reaven, G.M. (1988) Diabetes 37, 1595-1607
2. Chisholm, D.J. and Kraegen, E.W. (1991) in Textbook of diabetes (Vol. 1) (Pickup, J. and Williams, G., eds), pp. 192-197, Blackwell Scientific Publications
3. Ramirez, L.C. and Raskin, P. (1991) in Textbook of diabetes (Vol. 1) (Pickup, J. and Williams, G., eds), pp. 198-204, Blackwell Scientific Publications
4. Moller, D.E. and Flier, J.S. (1991) New Engl. J. Med. 325, 938-948, and references cited therein
5. Cerasi, E. (1992) in Insulin. Molecular Biology to Pathology (Ashcroft, F.M. and Ashcroft, S.J.H., eds), pp. 347-392, Oxford University Press
6. Kahn, C.R. (1994) Diabetes 43, 1066-1084
7. Reaven, G.M. (1995) Physiol. Rev. 75, 473-486
8. Taylor, S.I., Accili, D. and Imai, Y. (1995) Diabetes 43, 735-740
9. DeFronzo, R.A. (1990) Curr. Opin. Cardiol. 5, 586-593
10. Gerich, J.E. (1991) New Engl. J. Med. 321, 1231-1245
11. Bressler, R. and Johnstone, D. (1992) Diabetes Care 15, 792-805
12. Rachman, J. and Turner, R.C. (1995) Diabetic Med. 12, 467-478
13. Dunn, C.J. and Peters, D.H. (1995) Drugs 49, 721-749, and references cited therein
14. De Fronzo, R.A., Goodman, A.M. and the multicentre metformin study group (1995) New Engl. J. Med. 333, 541-549
15. Stumvoll, M. et al. (1995) New Engl. J. Med. 333, 550-554
16. Sohda, T. et al. (1982) Chem. Pharm. Bull. 30, 3580-3600
17. Fujita, T. et al. (1983) Diabetes 32, 804-810
18. Momose, Y. et al. (1991) Chem. Pharm. Bull. 39, 1440-1445
19. Hulin, B. et al. (1992) J. Med. Chem. 35, 1853-1864
20. Fujiwara, T. et al. (1988) Diabetes 37, 1549-1558
21. Cantello, B.C.C. et al. (1994) J. Med. Chem. 37, 3977-3985
22. Sohda, T. et al. (1992) J. Med. Chem. 35, 2617-2026
23. Hofman, C.A. and Colca, J.R. (1992) Diabetes Care 15, 1075-1077
24. Saltiel, A.R. and Horikoshi H. (1995) Curr. Opin. Endocrinol. Diabetes 2, 341-347
25. Iwamoto, Y. et al. (1991) Diabetes Care 14, 1083-1086
26. Suter, S.L. et al. (1992) Diabetes Care 15, 193-203
27. Nolan, J.J. et al. (1994) New Engl. J. Med. 331, 1188-1193
28. Kemnitz, J.W. et al. (1994) Diabetes 43, 204-211
29. Yoshioka, S. et al. (1993) Metabolism 42, 75-80
30. Al-Barazanji, K. et al. (1995) Diabetes 44, 71A
31. Toseland, N. et al. (1995) Diabetes 44, 127A
32. James, D.E. and Piper, R.C. (1994) J. Cell Biol. 126, 1123-1126, and references cited therein
33. Stephens, J.M. and Pilch, P.F. (1995) Endocrine Rev. 16, 529-546, and references cited therein
34. Kahn, B.B. (1992) J. Clin. Invest. 89, 1367-1374, and references cited therein
35. Hofman, C.A., Lorenz, K. and Colca, J.R. (1991) Endocrinology 129, 1915-1925
36. Young, P.W. et al. (1995) Diabetes 44, 1087-1092
37. Hirshman, M.F. et al. (1995) Biochem. Biophys. Res. Commun. 208, 835-845
38. Sandouk, T., Reda, D. and Hofman, C.A. (1993) Endocrinology 133, 352-359
39. Kletzien, R.F., Clarke, S.D. and Ulrich, R.G. (1992) Mol. Pharmacol. 41, 393-398
40. Sandouk, T., Reda, D. and Hofman, C.A. (1993) Am. J. Physiol. 264, C1600-C1608
41. Kletzien, R.F. et al. (1992) Mol. Pharmacol. 42, 558-562
42. Harris, P.K.W. and Kletzien, R.F. (1994) Mol. Pharmacol. 45, 439-445
43. Hresko, R.C. et al. (1988) Proc. Natl Acad. Sci. USA 85, 8835-8839
44. Hresko, R.C. et al. (1990) J. Biol. Chem. 265, 21075-21085
45. Ibrahim, A. et al. (1994) Mol. Pharmacol. 46, 1070-1076
46. Lehmann, J.M. et al. (1995) J. Biol. Chem. 270, 12853-12956
47. Ungar, R.H. (1995) Diabetes 44, 863-870
48. Oakes, N.D. et al. (1994) Diabetes 43, 1203-1210
49. Onuma, T. et al. (1994) Curr. Ther. Res. 55, 416-421
50. Chaiken, R.L. et al. (1995) Diabetologia 38, 1307-1312
51. Kissebah, A.H. and Krakower, G.R. (1994) Physiol. Rev. 74, 761-811, and references cited therein
52. Arch, J.R.S. and Kaumann, A.J. (1993) Med. Res. Rev. 13, 663-729
53. Arch, J.R.S. et al. (1984) Nature 309, 163-165
54. Emorine, J.L. et al. (1991) Biochem. Pharmacol. 41, 853-859
55. Blin, N. et al. (1993) Mol. Pharmacol. 44, 1094-1104
56. Howe, R. (1993) Drugs of the Future 18, 529-549, and references cited therein
57. Arch, J.R.S. et al. (1991) in Obesity and Cachexia (Rothwell, N.J. and Stock, M.J., eds), pp. 241-268, and references cited therein, John Wiley & Sons
58. Largis, E.E. et al. (1994) Drug Dev. Res. 32, 69-76, and references cited therein
59. Abe, H., Minokoshi, Y. and Shimazu, T. (1993) J. Endocrinol. 139, 479-486
60. Rochet, N. et al. (1988) Am. J. Physiol. 255, E101-E109
61. Le Marchand-Brustel, Y. et al. (1990) Endocrinology 127, 2687-2695
62. Walston, J. et al. (1995) New Engl. J. Med. 333, 343-347
63. Widen, E. et al. (1995) New Engl. J. Med. 333, 348-351
64. Clement, K. et al. (1995) New Engl. J. Med. 333, 352-354
65. Kadowaki, H. et al. (1995) Biochem. Biophys. Res. Commun. 215, 555-560
66. Blin, N. et al. (1994) Br. J. Pharmacol. 112, 911-919
67. Liggett, S.B. (1992) Mol. Pharmacol. 42, 634-637
68. Bousquet-Melou, A. et al. (1994) Am. J. Physiol. 267, R115-123
69. Zaagsma, J. and Nahorski, S.R. (1990) Trends Pharmacol. Sci. 11, 3-7
70. Lonnqvist, F. et al. (1993) Br. J. Pharmacol. 110, 929-936
71. Sillence, M.N. et al. (1993) Br. J. Pharmacol. 109, 1157-1163
72. Thomas, R.F. and Liggett, S.B. (1993) Mol. Pharmacol. 43, 343-348
73. Kreif, S. et al. (1993) J. Clin. Invest. 91, 344-349